BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8741261)

  • 1. Potential transforming-ability by internal deletion of the bovine c-myb gene.
    Ohozono T; Ishiguro N; Horiuchi M; Shinagawa M
    J Vet Med Sci; 1996 Apr; 58(4):305-10. PubMed ID: 8741261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A spontaneous internal deletion of the c-myb protooncogene enhances transcriptional activation in bovine T lymphoma cells.
    Ishiguro N; Ohzono T; Shinagawa T; Horiuchi M; Shinagawa M
    J Biol Chem; 1994 Oct; 269(43):26822-9. PubMed ID: 7929419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.
    Hu YL; Ramsay RG; Kanei-Ishii C; Ishii S; Gonda TJ
    Oncogene; 1991 Sep; 6(9):1549-53. PubMed ID: 1923521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene.
    Press RD; Reddy EP; Ewert DL
    Mol Cell Biol; 1994 Apr; 14(4):2278-90. PubMed ID: 8139533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proto-oncogene c-myb is expressed in sporadic bovine lymphoma, but not in enzootic bovine leukosis.
    Asahina M; Ishiguro N; Wu D; Goryo M; Davis WC; Okada K
    J Vet Med Sci; 1996 Dec; 58(12):1169-74. PubMed ID: 8996698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of carboxy-terminal deletion mutants of c-Myb.
    Wang DM; Dubendorff JW; Woo CH; Lipsick JS
    J Virol; 1999 Jul; 73(7):5875-86. PubMed ID: 10364339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instability of the 12-nucleotide repeat in c-myb gene of bovine T-lymphoma cells.
    Shinagawa T; Ishiguro N; Horiuchi M; Shinagawa M
    J Vet Med Sci; 1997 Nov; 59(11):1071-4. PubMed ID: 9409529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein truncation is required for the activation of the c-myb proto-oncogene.
    Grässer FA; Graf T; Lipsick JS
    Mol Cell Biol; 1991 Aug; 11(8):3987-96. PubMed ID: 2072904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of an alternatively spliced form of c-Myb results in increases in transactivation and transforms avian myelomonoblasts.
    Woo CH; Sopchak L; Lipsick JS
    J Virol; 1998 Aug; 72(8):6813-21. PubMed ID: 9658130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain.
    Aziz N; Miglarese MR; Hendrickson RC; Shabanowitz J; Sturgill TW; Hunt DF; Bender TP
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6429-33. PubMed ID: 7604007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two c-myb proteins differing by their aminotermini exhibit different transcriptional transactivation activities (yeast/reporter-effector system).
    Punyammalee B; Crabeel M; de Lannoy C; Perbal B; Glansdorff N
    Oncogene; 1991 Jan; 6(1):11-9. PubMed ID: 1992438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis.
    Melotti P; Calabretta B
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5313-8. PubMed ID: 8643572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G; Tantravahi R; Oh IH; Reddy EP
    Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of c-myb exon 9 induced by insertion of repeats.
    Shinagawa T; Ishiguro N; Horiuchi M; Matsui T; Okada K; Shinagawa M
    Oncogene; 1997 Jun; 14(23):2775-83. PubMed ID: 9190893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression cloning of oncogenes by retroviral transfer of cDNA libraries.
    Whitehead I; Kirk H; Kay R
    Mol Cell Biol; 1995 Feb; 15(2):704-10. PubMed ID: 7823939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
    Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
    Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid induction of B-cell lymphomas by avian leukosis virus.
    Beemon KL; O'Reilly MM; Smith MR; Smith RE; Dunkel I; Hayward WS
    Leukemia; 1997 Apr; 11 Suppl 3():179-82. PubMed ID: 9209336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell transformation by dbl oncogene.
    Zangrilli D; Eva A
    Methods Enzymol; 1995; 256():347-58. PubMed ID: 7476452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.